Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1007125-06-5

Post Buying Request

1007125-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1007125-06-5 Usage

Description

(1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate is a complex synthetic chemical compound characterized by a bicyclic structure. It features a tert-butyl group, a carboxylate group, and multiple hydroxyl and oxo functional groups. The inclusion of an aza group signifies the presence of a nitrogen atom within the bicyclic framework. This unique arrangement of functional groups and structural features suggests potential applications in pharmaceutical or chemical research, although the exact properties and uses are not specified without further context or research.

Uses

Used in Pharmaceutical Research:
(1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate is used as a research compound for exploring its potential pharmaceutical applications. The presence of multiple functional groups and a unique bicyclic structure may offer opportunities for the development of new drugs or drug candidates, particularly in areas where its specific chemical properties could be leveraged for therapeutic effects.
Used in Chemical Research:
In the field of chemical research, (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate serves as a subject for studying the properties and reactions of complex organic molecules. Its unique structure and functional groups can be investigated to understand how they influence chemical behavior, potentially leading to advancements in synthetic chemistry or the discovery of new chemical processes.
Without additional information on specific applications or industries, these general uses in pharmaceutical and chemical research provide a starting point for understanding the potential relevance of (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate in scientific and industrial contexts. Further research and development would be necessary to fully realize its practical applications and benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 1007125-06-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,1,2 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1007125-06:
(9*1)+(8*0)+(7*0)+(6*7)+(5*1)+(4*2)+(3*5)+(2*0)+(1*6)=85
85 % 10 = 5
So 1007125-06-5 is a valid CAS Registry Number.

1007125-06-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-(1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

1.2 Other means of identification

Product number -
Other names tert-butyl (1R,4S,5R,6S)-5,6-dihydroxy-3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1007125-06-5 SDS

1007125-06-5Relevant articles and documents

RNAs Containing Carbocyclic Ribonucleotides

Akabane-Nakata, Masaaki,Chickering, Tyler,Harp, Joel M.,Schlegel, Mark K.,Matsuda, Shigeo,Egli, Martin,Manoharan, Muthiah

supporting information, p. 525 - 530 (2022/01/12)

Toward the goal of evaluation of carbocyclic ribonucleoside-containing oligonucleotide therapeutics, we developed convenient, scalable syntheses of all four carbocyclic ribonucleotide phosphoramidites and the uridine solid-support building block. Crystall

Efficient and stereoselective synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA)

-

, (2016/06/01)

The invention provides a new convergent approach for the synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) from a readily available starting material (Vince lactam) in fourteen steps. An efficient and practical methodology for stereospecifi

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

-

Page/Page column 91, (2008/06/13)

This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1007125-06-5